Literature DB >> 26350380

Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice.

Michelle Carvalho de Rezende1, Emília Souza Araújo1, João Marcelo Peixoto Moreira1, Vanessa Fernandes Rodrigues1, Jailza Lima Rodrigues1, Cíntia A de Jesus Pereira1, Deborah Negrão-Corrêa2.   

Abstract

Multiple schistosome and soil-transmitted nematode infections are frequently reported in human populations living in tropical areas of developing countries. In addition to exposure factors, the host immune response plays an important role in helminth control and morbidity in hosts with multiple infections; however, these aspects are difficult to evaluate in human populations. In the current study, female Swiss mice were simultaneously co-infected with Strongyloides venezuelensis and Schistosoma mansoni or infected with St. venezuelensis at 2, 4, or 14 weeks after Sc. mansoni infection. The simultaneously infected mice showed a similar parasite burden for St. venezuelensis compared with mono-infected mice. In contrast, there was a significant reduction of St. venezuelensis burden (primarily during the migration of the larvae) in mice that were previously infected with Sc. mansoni at the acute or chronic phase. Independent of the stage of Sc. mansoni infection, the St. venezuelensis co-infection was capable of inducing IL-4 production in the small intestine, increasing the IgE concentration in the serum and increasing eosinophilia in the lungs and intestine. This result suggests that the nematode infection stimulates local type 2 immune responses independently of the schistosomiasis stage. Moreover, previous Sc. mansoni infection stimulated early granulocyte infiltration in the lungs and trematode-specific IgM and IgG1 production that recognized antigens from St. venezuelensis infective larvae; these immune responses would act in the early control of St. venezuelensis larvae. Our data suggest that the effect of multiple helminth infections on host susceptibility and morbidity largely depends on the species of parasite and the immune response.

Entities:  

Keywords:  Co-infection; Cross-reactive antibody production; Schistosoma mansoni; Strongyloides venezuelensis; Tissue eosinophilia

Mesh:

Substances:

Year:  2015        PMID: 26350380     DOI: 10.1007/s00436-015-4706-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  55 in total

Review 1.  Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.

Authors:  D W Dunne; E J Pearce
Journal:  Microbes Infect       Date:  1999-06       Impact factor: 2.700

Review 2.  Natural regulatory T cells and parasites: a common quest for host homeostasis.

Authors:  Yasmine Belkaid; Rebecca B Blank; Isabelle Suffia
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

Review 3.  Intestinal strongyloidiasis: recognition, management, and determinants of outcome.

Authors:  Ronald Concha; William Harrington; Arvey I Rogers
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

Review 4.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

5.  Infection with Strongyloides venezuelensis induces transient airway eosinophilic inflammation, an increase in immunoglobulin E, and hyperresponsiveness in rats.

Authors:  Micheline R Silveira; Kênia P Nunes; Denise C Cara; Danielle G Souza; Ary Corrêa; Mauro M Teixeira; Deborah Negrão-Corrêa
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.

Authors:  A F Porto; F A Neva; H Bittencourt; W Lisboa; R Thompson; L Alcântara; E M Carvalho
Journal:  Parasite Immunol       Date:  2001-09       Impact factor: 2.280

8.  Human helminth co-infection: no evidence of common genetic control of hookworm and Schistosoma mansoni infection intensity in a Brazilian community.

Authors:  Rachel L Pullan; Jeffrey M Bethony; Stefan M Geiger; Rodrigo Correa-Oliveira; Simon Brooker; Rupert J Quinnell
Journal:  Int J Parasitol       Date:  2009-08-20       Impact factor: 3.981

9.  Intraepithelial infiltration of eosinophils and their contribution to the elimination of adult intestinal nematode, Strongyloides venezuelensis in mice.

Authors:  Mohamed El-Malky; Haruhiko Maruyama; Yoshiaki Hirabayashi; Shoichi Shimada; Ayako Yoshida; Teruaki Amano; Akira Tominaga; Kiyoshi Takatsu; Nobuo Ohta
Journal:  Parasitol Int       Date:  2003-03       Impact factor: 2.230

Review 10.  The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40.

Authors:  M J Stadecker; H J Hernandez
Journal:  Parasite Immunol       Date:  1998-05       Impact factor: 2.280

View more
  3 in total

1.  Recombinant Haemonchus contortus 24 kDa excretory/secretory protein (rHcES-24) modulate the immune functions of goat PBMCs in vitro.

Authors:  Javaid Ali Gadahi; Baojie Li; Muhammad Ehsan; Shuai Wang; Zhenchao Zhang; Yujian Wang; Muhammad Waqqas Hasan; Ruofeng Yan; Xiaokai Song; Lixin Xu; Xiangrui Li
Journal:  Oncotarget       Date:  2016-12-20

Review 2.  Infection against infection: parasite antagonism against parasites, viruses and bacteria.

Authors:  Shi-Shi Shen; Xiao-Yan Qu; Wei-Zhe Zhang; Jian Li; Zhi-Yue Lv
Journal:  Infect Dis Poverty       Date:  2019-06-15       Impact factor: 4.520

3.  Recombinant protein of Haemonchus contortus small GTPase ADP-ribosylation factor 1 (HcARF1) modulate the cell mediated immune response in vitro.

Authors:  Javaid Ali Gadahi; Muhammad Ehsan; Shuai Wang; Zhenchao Zhang; Ruofeng Yan; Xiaokai Song; Lixin Xu; Xiangrui Li
Journal:  Oncotarget       Date:  2017-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.